Tanelian D L, Bisla K
Department of Anesthesiology, University of Texas, Southwestern Medical Center, Dallas 75235-9068.
Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3024-8.
Corneal epithelial wound healing is an important process necessary for maintenance of visual integrity. Corneal epithelial wound healing occurs by cellular migration and proliferation. However, the molecular basis of reepithelialization is not known. To investigate individual molecular contributions to the wound healing process, an in vitro corneal preparation comparable to the in vivo condition is needed. This investigation developed a new whole mount in vitro rabbit cornea preparation and studied epithelial wound healing rates for epithelial and subepithelial wounds. The wound closure rates obtained in this study for epithelial and subepithelial wound healing (52 +/- 14 microns/hr and 38 +/- 7 microns/hr, respectively) are comparable to in vivo rates of wound healing determined by other laboratories for rabbits. This preparation, achieved by functionally separating the epithelial and endothelial sides of the cornea, allows application of agents to the cornea in a manner that approximates the in vivo condition. This in vitro system is promising for future studies designed to investigate corneal wound healing while reducing potential ocular discomfort associated with in vivo corneal wounding.
角膜上皮伤口愈合是维持视觉完整性所必需的重要过程。角膜上皮伤口愈合通过细胞迁移和增殖发生。然而,再上皮化的分子基础尚不清楚。为了研究个体分子对伤口愈合过程的贡献,需要一种与体内情况相当的体外角膜制剂。本研究开发了一种新的体外兔角膜全层制剂,并研究了上皮和上皮下伤口的上皮伤口愈合率。本研究中获得的上皮和上皮下伤口愈合的伤口闭合率(分别为52±14微米/小时和38±7微米/小时)与其他实验室测定的兔体内伤口愈合率相当。这种通过在功能上分离角膜的上皮和内皮面而实现的制剂,能够以接近体内情况的方式将药物应用于角膜。这种体外系统对于未来旨在研究角膜伤口愈合同时减少与体内角膜损伤相关的潜在眼部不适的研究很有前景。